AAAAAA
Results:
1-15
|
Results: 15
Authors:
GOLLNICK HPM
Citation: Hpm. Gollnick, THE PSORIATIC PATIENT AND THE USE OF TOPICAL ANTIPSORIATICS, Journal of dermatological treatment, 9, 1998, pp. 7-11
Authors:
JAPPE U
FRANKE I
REINHOLD D
GOLLNICK HPM
Citation: U. Jappe et al., SEBOTROPIC DRUG REACTION RESULTING FROM KAVA-KAVA EXTRACT THERAPY - ANEW ENTITY, Journal of the American Academy of Dermatology, 38(1), 1998, pp. 104-106
Authors:
GOLLNICK HPM
DUMMLER U
Citation: Hpm. Gollnick et U. Dummler, RETINOIDS, Clinics in dermatology, 15(5), 1997, pp. 799-810
Authors:
SCHRAMM M
GOLLNICK HPM
Citation: M. Schramm et Hpm. Gollnick, ACNE - BASICS, PATHOGENESIS, DIFFERENTIAL-DIAGNOSIS, CLINIC AND THERAPY - DEVELOPMENT OF AN INTERACTIVE HYPERMEDIA APPLICATION ON CD-ROM FOR COMPUTER-BASED LEARNING AND INSTRUCTION, Journal of investigative dermatology, 108(3), 1997, pp. 84-84
Authors:
SCHRAMM M
PFROMMERPAPE C
ZOUBOULIS CC
GOLLNICK HPM
Citation: M. Schramm et al., THE SAPHO SYNDROME - DOES IT EXIST, Journal of investigative dermatology, 108(3), 1997, pp. 90-90
Authors:
SMITH CM
SCHUSTER G
KONIG W
GOLLNICK HPM
Citation: Cm. Smith et al., INFLUENCE OF DIFFERENT FORMULATIONS ON THE EFFICACY OF TOPICAL NADIFLOXACIN (OPC-7251), Journal of investigative dermatology, 108(3), 1997, pp. 123-123
Authors:
GUTHKE R
MAUCH H
FISCHER M
ANSORGE S
FRANKE I
GOLLNICK HPM
Citation: R. Guthke et al., GENERALIZED ATYPICAL MYCOBACTERIOSIS IN A PATIENT WITH NON-HIV-ASSOCIATED IMMUNODEFICIENCY AND ISOLATION OF A NEW MYCOBACTERIUM SPECIES, EJD. European journal of dermatology, 6(3), 1996, pp. 178-180
Authors:
GOLLNICK HPM
HOPFENMULLER W
HEMMES C
CHUN SC
SCHMID C
SUNDERMEIER K
BIESALSKI HK
Citation: Hpm. Gollnick et al., SYSTEMIC BETA-CAROTENE PLUS TOPICAL UV-SUNSCREEN ARE AN OPTIMAL PROTECTION AGAINST HARMFUL EFFECTS OF NATURAL UV-SUNLIGHT - RESULTS OF THE BERLIN-EILATH STUDY, EJD. European journal of dermatology, 6(3), 1996, pp. 200-205
Authors:
BIESALSKI HK
HEMMES C
HOPFENMULLER W
SCHMID C
GOLLNICK HPM
Citation: Hk. Biesalski et al., EFFECTS OF CONTROLLED EXPOSURE OF SUNLIGHT ON PLASMA AND SKIN LEVELS OF BETA-CAROTENE, Free radical research, 24(3), 1996, pp. 215-224
Authors:
GOLLNICK HPM
Citation: Hpm. Gollnick, ORAL RETINOIDS - EFFICACY AND TOXICITY IN PSORIASIS, British journal of dermatology, 135, 1996, pp. 6-17
Authors:
GARMANN EM
GOLLNICK HPM
Citation: Em. Garmann et Hpm. Gollnick, IMMUNOPHENOTYPING OF THE CELLULAR INFILTRATE IN THE EARLY ELICITATIONPHASE OF CONTACT-DERMATITIS IN THE SKIN OF PRESENSITIZED ATOPIC INDIVIDUALS, Archives of dermatological research, 287(2), 1995, pp. 129-136
Authors:
GOLLNICK HPM
THIES W
Citation: Hpm. Gollnick et W. Thies, IDIOPATHIC PUSTULOUS AND BULLOUS VARIANT OF SWEETS-SYNDROME - COMMENT, Hautarzt, 46(4), 1995, pp. 283-283
Authors:
BLUMEPEYTAVI U
GOLLNICK HPM
ORFANOS CE
Citation: U. Blumepeytavi et al., MARYJOSEPH,SISTER NODULE - UMBILICAL METASTASIS, EJD. European journal of dermatology, 4(8), 1994, pp. 655-656
Authors:
ZOUBOULIS CC
GOLLNICK HPM
ORFANOS CE
Citation: Cc. Zouboulis et al., LIVEDO RACEMOSA DUE TO CHOLESTEROL CRYSTAL EMBOLIZATION, EJD. European journal of dermatology, 4(7), 1994, pp. 569-570
Authors:
GOLLNICK HPM
VOGT K
HERMANN J
BLUME U
HAHN H
HAUSTEIN UF
ORFANOS CE
Citation: Hpm. Gollnick et al., TOPICAL QUINOLONE OPC-7251 - A CLINICAL AND MICROBIOLOGICAL STUDY IN ACNE, EJD. European journal of dermatology, 4(3), 1994, pp. 210-215
Risultati:
1-15
|